Korean Circ J.  2020 Apr;50(4):328-329. 10.4070/kcj.2020.0040.

Can Genoss DESâ„¢ Stand Out in the Crowd of Stents?

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea. jaehpark@cnu.ac.kr

Abstract

No abstract available.


MeSH Terms

Stents*

Cited by  1 articles

A First-in-Man Clinical Evaluation of Sirolimus and Ascorbic Acid-Eluting Stent Systems: a Multicenter, Subject-Blinded, Randomized Study
Young-Hyo Lim, Ji Hyun Youn, Soon-Jun Hong, Tae-Hoon Ahn, Junghan Yoon, Jun-Kyu Park, Hyo-Soo Kim
Korean Circ J. 2021;51(12):1001-1014.    doi: 10.4070/kcj.2021.0161.


Reference

1. Holmes DR Jr, Kereiakes DJ, Laskey WK, et al. Thrombosis and drug-eluting stents: an objective appraisal. J Am Coll Cardiol. 2007; 50:109–118.
2. El-Hayek G, Bangalore S, Casso Dominguez A, et al. Meta-analysis of randomized clinical trials comparing biodegradable polymer drug-eluting stent to second-generation durable polymer drug-eluting stents. JACC Cardiovasc Interv. 2017; 10:462–473.
Article
3. Yang HM, Seo KW, Yoon J, et al. Clinical and angiographic outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal bioresorbable polymer. Korean Circ J. 2017; 47:898–906.
Article
4. Youn YJ, Yoo SY, Lee JW, et al. Safety and efficacy of a new ultrathin sirolimus-eluting stent with abluminal biodegradable polymer in real-world practice. Korean Circ J. 2020; 50:317–327.
Article
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr